Format

Send to

Choose Destination
Vaccine. 2015 Jun 8;33 Suppl 2:B52-4. doi: 10.1016/j.vaccine.2015.02.071.

Vaccines: from valuation to resource allocation.

Author information

1
Harvard T.H. Chan School of Public Health, Boston, MA, United States. Electronic address: dbloom@hsph.harvard.edu.
2
Institute of Medicine, National Academy of Sciences, Washington, DC, United States.

Abstract

This review focuses on selected challenges and opportunities concerning broader valuation of vaccines and immunization. The challenges involve conceptualizing and measuring the value of vaccines, while the opportunities relate to the strategic and systematic use of that information in health policy decisions that range from the adoption of particular vaccines in national immunization plans to the allocation of resources to vaccine research, development, and delivery. Clarifying the demonstrable individual, family, and community-level benefits of vaccines will allow the public health community to make better-informed and more meaningful comparisons of the costs of vaccines in relation to their full benefits. Taking advantage of this opportunity will require enhanced data collection and the development of strategic planning tools for transparently assessing trade-offs among the myriad attributes of different vaccines in various social and economic contexts.

KEYWORDS:

Data collection; Resource allocation; Strategic planning tools

PMID:
26022569
DOI:
10.1016/j.vaccine.2015.02.071
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center